Founded in 2000, Cambrooke is a private equity-backed, Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with serious chronic unmet medical needs. The company works with physicians and researchers from around the world to develop, test and commercialize products that are today focused on inborn errors of metabolism and intractable epilepsy.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/11/16 | undisclosed | Series C |
Galen Partners Seventure Partners | undisclosed |
